Lexicon Pharmaceuticals (Nasdaq: LXRX) reports Q1 LOSS of $0.16, 3 cents below the analyst estimate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE